The Mankind Pharma MD further revealed that flavors like kala khatta and sabudana were merely marketing gimmicks and ...

Mankind's revenue from operations rose to Rs 3,230 crore in Q3FY25, a 24 per cent Y-o-Y rise from Rs 2,607 crore reported in ...

Mankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue ...

In the latest episode of the podcast ‘Figuring Out With Raj Shamani’, Rajeev Juneja of Mankind Pharma discussed regional ...

Not all flavoured condoms are created equal. Some sell more in south India, while others have found a niche in the north, per a leading condom brand in India.

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3050 in its ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Mankind Pharma Ltd.'s share price declined more than 5% during early trade on Friday after the company's third-quarter ...

IST, the barometer index, the S&P BSE Sensex, rallied 272.49 points or 0.35% to 76,808.15. The Nifty 50 index added 111.50 points or 0.48% to 23,274.60.

India's Mankind Pharma reported a smaller-than-expected third-quarter profit on Thursday, hurt by a sharp rise in expenses.

Mankind Pharma's net profit fell 16.5% to Rs 384 crore in Q3 FY25, while revenue rose 24% to Rs 3,230 crore. The company's ...

NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out ...